-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Biora Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2024.
- Biora Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $48 K.
- Biora Therapeutics, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was -$42 K.
- Biora Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2023 was -$90 K, a 78.6% increase from 2022.
- Biora Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was -$420 K, a 253% decline from 2021.
- Biora Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$119 K, a 99.7% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)